Jim Frates
About Jim Frates
Jim Frates serves as the Chief Financial Officer at Amylyx Pharmaceuticals, a position he has held since 2021. He previously spent 23 years as CFO at Alkermes and has a background in finance from his time at Robertson Stephens.
Current Role at Amylyx Pharmaceuticals
Jim Frates serves as the Chief Financial Officer at Amylyx Pharmaceuticals, a position he has held since 2021. He is based in Cambridge, Massachusetts. In this role, he is responsible for overseeing the financial operations of the company, ensuring financial stability, and supporting strategic initiatives.
Previous Experience at Alkermes
Prior to his role at Amylyx Pharmaceuticals, Jim Frates worked at Alkermes as Chief Financial Officer for 23 years, from 1998 to 2021. During his tenure, he contributed to the financial management and strategic direction of the company, playing a key role in its growth and development in the biopharmaceutical sector.
Experience at Robertson Stephens
Jim Frates held the position of Vice President at Robertson Stephens from 1992 to 1998. During his six years in this role, he was involved in financial services within the San Francisco Bay Area, contributing to investment banking and financial advisory services.
Educational Background
Jim Frates studied at St. Paul's School before pursuing higher education. He earned a Bachelor's degree in Political Science and Government from Harvard University. Additionally, he attended Harvard Business School from 1994 to 1996, furthering his education in business management.